Insider Cluster (2 insiders) ·Filed Jun 8, 2026

USNA

USANA HEALTH SCIENCES INC
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago
Insider cluster: 2 insiders, $147K total
Actionable Insight • Neutral

The dollar value of the cluster is de minimis for a $333M company. No bearish signal from these sales. Monitor the next 10-Q for fundamental trends, as the market cap suggests the business is already under pressure.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
USNA ▲ +17.73% at T+20d
NEUTRAL call ✓ call won +17.73% · α vs SPY +16.28% · entry $19.01 → $22.38
Next anchor: T+60d due 4w ago
Latest observation: T+57 -32.13% FF3 residual α
Entry anchored
Jun 8, 03:59 PM ET
via exchange tick
T+1d
+0.84%
call +0.84% · α +2.42%
$19.17
settled 4mo ago
T+5d
+2.10%
call +2.10% · α -0.31%
$19.41
settled 4mo ago
T+20d
+17.73%
call +17.73% · α +16.28%
$22.38
settled 3mo ago
T+60d
—
call — · α —
—
due 4w ago

Price Chart

Loading chart...

Executive Summary

Two insiders at USANA Health Sciences sold a combined $147K in open-market transactions over a one-week window, representing ~0.044% of the company's $333M market cap. The trades are routine in dollar magnitude and involve the Chief People Officer and a Director — no C-suite signal of concern.

Key Financial Metrics

Direction
selling
Total Value
$147.0K
Insiders
2

Key Facts

  • Two insiders sold (Jones: $103K, Fleming: $44K) between June 1–8, 2026
  • Total cluster value of $147K is ~0.044% of $333M market cap
  • Chief People Officer sold 5,561 shares at $18.50; Director sold 2,500 shares at $17.93
  • All transactions are open-market sales (Code S)
  • No insider purchases were reported in the window

Financial Impact

Insider sales total $147K, representing approximately 0.044% of market capitalization — trivial relative to company size.

insider holdings

Risk Factors

  • Prior insight reports on USNA had negative T+5 performance, suggesting the stock may face headwinds regardless of insider signal
  • Analyst consensus is heavily bearish (6 sell-equivalent ratings, only 3 hold, 0 buy)

Market Snapshot

Exchange
NYSE
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-USNA-1780956682452
5 reports for USNA
Performance horizon
Filters
Rows
Reports for USNA — sortable, filterable
TypeNow
Jun 16, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$19.01 $21.40▲ +12.57%▲ +12.37%$14.82 (−22.04%)
Jun 8, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$19.01 $22.38▲ +17.73%▲ +16.28%$14.82 (−22.04%)
Jun 1, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$18.05 $21.72▲ +20.33%▲ +21.90%$14.82 (−17.89%)
May 29, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$18.30 $21.01▲ +14.81%▲ +16.60%$14.82 (−19.02%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$18.84 $20.70▲ +9.87%▲ +13.02%$14.82 (−21.34%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (34h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 8, 2026